CA2164155C - Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose - Google Patents

Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose Download PDF

Info

Publication number
CA2164155C
CA2164155C CA 2164155 CA2164155A CA2164155C CA 2164155 C CA2164155 C CA 2164155C CA 2164155 CA2164155 CA 2164155 CA 2164155 A CA2164155 A CA 2164155A CA 2164155 C CA2164155 C CA 2164155C
Authority
CA
Canada
Prior art keywords
brucella
vaccine
ops
polysaccharide
abortus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA 2164155
Other languages
English (en)
Other versions
CA2164155A1 (fr
Inventor
John W. Cherwonogrodzky
Jonathan P. Wong
Vincent L. Dininno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Department of National Defence
Original Assignee
Department of National Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Department of National Defence filed Critical Department of National Defence
Priority to CA 2164155 priority Critical patent/CA2164155C/fr
Priority to US08/672,063 priority patent/US5951987A/en
Publication of CA2164155A1 publication Critical patent/CA2164155A1/fr
Application granted granted Critical
Publication of CA2164155C publication Critical patent/CA2164155C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/098—Brucella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CA 2164155 1995-08-22 1995-11-30 Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose Expired - Lifetime CA2164155C (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CA 2164155 CA2164155C (fr) 1995-11-30 1995-11-30 Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose
US08/672,063 US5951987A (en) 1995-08-22 1996-09-16 Polysaccharide vaccine to enhance immunity against brucellosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2164155 CA2164155C (fr) 1995-11-30 1995-11-30 Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose

Publications (2)

Publication Number Publication Date
CA2164155A1 CA2164155A1 (fr) 1997-05-31
CA2164155C true CA2164155C (fr) 2005-06-21

Family

ID=4157067

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2164155 Expired - Lifetime CA2164155C (fr) 1995-08-22 1995-11-30 Vaccin a base de polysaccharide permettant d'ameliorer l'immunite contre la brucellose

Country Status (1)

Country Link
CA (1) CA2164155C (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444210B1 (en) 1996-07-03 2002-09-03 Her Majesty the Queen in right of Canada, as represented by the Minister of National Defence of Her Majesty′s Canadian Goverment Bacterial and synthetic polysaccharide immunomodulators that enhance general immunity

Also Published As

Publication number Publication date
CA2164155A1 (fr) 1997-05-31

Similar Documents

Publication Publication Date Title
JP2640525B2 (ja) 無毒の微生物とその使用
Witcombe et al. Strategies for anti-coccidial prophylaxis
US8669355B2 (en) Vaccine
Esteve-Gassent et al. Efficacy of a bivalent vaccine against eel diseases caused by Vibrio vulnificus after its administration by four different routes
JP2004536106A (ja) マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法
TW557214B (en) Attenuated live Neospora vaccine
Leal et al. Oral and parenteral vaccines against Flavobacterium columnare: evaluation of humoral immune response by ELISA and in vivo efficiency in Nile tilapia (Oreochromis niloticus)
JPH0811735B2 (ja) 抗原性遺伝子ワクチン
Fouz et al. Field testing of a vaccine against eel diseases caused by Vibrio vulnificus
CA1336406C (fr) Composition de vaccin pour bovins et methode pour la prevention de l'infection par les trichomas a l'aide de celle-ci
Ahangarzadeh et al. Effect of killed autogenous polyvalent vaccines against Vibrio harveyi, V. alginolyticus and Streptococcus iniae on survival and immunogenicity of Asian seabass (Lates calcarifer)
KR20030036647A (ko) 마이코플라스마 하이오뉴모니에에 대한 온도-감수성 생 백신
Parmley et al. Protective effects of immunization with a recombinant cyst antigen in mouse models of infection with Toxoplasma gondii tissue cysts
US5951987A (en) Polysaccharide vaccine to enhance immunity against brucellosis
Villarreal et al. Proliferative and T-cell specific interleukin (IL-2/IL-4) production responses in spleen cells from mice vaccinated with aroA live attenuated Salmonella vaccines
US7442374B2 (en) Composition for increasing the survival to slaughter rate of piglets
Chakrabarti et al. Killed oral Shigella vaccine made from Shigella flexneri 2a protects against challenge in the rabbit model of shigellosis
US20020187162A1 (en) Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
WO1993010815A1 (fr) Mutants non encapsules de bacteries utiles comme vaccins
Marx Vaccinating with Bacterial Pili: Protection against a number of diseases, including gonorrhea, may be possible by immunizing with the bacterial surface components called pili
AU2018359019B2 (en) Vaccine
US6881412B1 (en) Modified live Flavobacterium columnare against columnaris disease in fish
RU2467763C2 (ru) Комбинации из делеций генов для живых ослабленных вакцинных штаммов shigella
US12005110B2 (en) Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae
Johnson et al. Intracerebral infection of mice with ovine strains of Chlamydia psittaci: an animal screening test for the assay of vaccines

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20151130